Endogenous Catecholamines in Immune Cells: Discovery, Functions And Clinical Potential as Therapeutic Targets
Beta-Blockers Emerge as Beneficial in Early and Triple-Negative Breast Cancer: Reasons Why and the Role of a Sympathetic Overdrive in TNBC Patients
Donna Jackson Nakazawa and Her New Book, THE ANGEL AND THE ASSASSIN: The Tiny Brain Cell that Changed the Course of Medicine
Beta-Blockers Emerge as Beneficial in Early and Triple-Negative Breast Cancer: Reasons Why and the Role of a Sympathetic Overdrive in TNBC PatientsDecember 21, 2022
Platelet-activating anti-PF4 antibodies linked to the vaccine-induced immune thrombotic thrombocytopeniaApril 19, 2021
The IL-6 Inhibitors Tocilizumab and Sarilumab and COVID-19 Treatment: Controversies but Potential Efficacy in Severe CasesFebruary 6, 2021
The Top 10 BrainImmune Updates and Why These Stories Are Fundamentally and Clinically ImportantDecember 8, 2022
Encouraging Results from Phase 2a COVID-19 Clinical Trial with the Oral Direct-Acting Antiviral MolnupiravirJuly 7, 2021
Bamlanivimab (an Investigational Monoclonal Antibody): FDA Authorizes its Emergency Use for the Treatment of Mild to Moderate COVID-19November 11, 2020
